These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 31407970

  • 1. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.
    Bouziane C, Filatova OG, Schrantee A, Caan MWA, Vos FM, Reneman L.
    Radiology; 2019 Oct; 293(1):186-192. PubMed ID: 31407970
    [No Abstract] [Full Text] [Related]

  • 2. Methylphenidate Effects on Cortical Thickness in Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
    Walhovd KB, Amlien I, Schrantee A, Rohani DA, Groote I, Bjørnerud A, Fjell AM, Reneman L.
    AJNR Am J Neuroradiol; 2020 May; 41(5):758-765. PubMed ID: 32414901
    [Abstract] [Full Text] [Related]

  • 3. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH, Nagy P, Childress AC, Frick G, Yan B, Pliszka S.
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [Abstract] [Full Text] [Related]

  • 4. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD.
    Tamminga HGH, Reneman L, Schrantee A, Bottelier MA, Bouziane C, Geurts HM, Groenman AP.
    Eur Neuropsychopharmacol; 2021 May; 46():1-13. PubMed ID: 33735707
    [Abstract] [Full Text] [Related]

  • 5. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
    Schrantee A, Tamminga HG, Bouziane C, Bottelier MA, Bron EE, Mutsaerts HJ, Zwinderman AH, Groote IR, Rombouts SA, Lindauer RJ, Klein S, Niessen WJ, Opmeer BC, Boer F, Lucassen PJ, Andersen SL, Geurts HM, Reneman L.
    JAMA Psychiatry; 2016 Sep 01; 73(9):955-62. PubMed ID: 27487479
    [Abstract] [Full Text] [Related]

  • 6. Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder.
    Schweren LJ, Hartman CA, Zwiers MP, Heslenfeld DJ, Franke B, Oosterlaan J, Buitelaar JK, Hoekstra PJ.
    Eur Neuropsychopharmacol; 2016 Apr 01; 26(4):674-83. PubMed ID: 26899587
    [Abstract] [Full Text] [Related]

  • 7. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K, Halari R, Mohammad AM, Taylor E, Brammer M.
    Biol Psychiatry; 2011 Aug 01; 70(3):255-62. PubMed ID: 21664605
    [Abstract] [Full Text] [Related]

  • 8. Attention deficit/hyperactivity disorder and medication with stimulants in young children: a DTI study.
    de Luis-García R, Cabús-Piñol G, Imaz-Roncero C, Argibay-Quiñones D, Barrio-Arranz G, Aja-Fernández S, Alberola-López C.
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar 03; 57():176-84. PubMed ID: 25445066
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan.
    Takahashi N, Koh T, Tominaga Y, Saito Y, Kashimoto Y, Matsumura T.
    World J Biol Psychiatry; 2014 Aug 03; 15(6):488-98. PubMed ID: 24456065
    [Abstract] [Full Text] [Related]

  • 10. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.
    Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G.
    Pediatrics; 2001 Oct 03; 108(4):883-92. PubMed ID: 11581440
    [Abstract] [Full Text] [Related]

  • 11. Effects of Methylphenidate on Sleep Functioning in Children with Attention-Deficit/Hyperactivity Disorder.
    Becker SP, Froehlich TE, Epstein JN.
    J Dev Behav Pediatr; 2016 Jun 03; 37(5):395-404. PubMed ID: 27011002
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. COMT genotype affects brain white matter pathways in attention-deficit/hyperactivity disorder.
    Hong SB, Zalesky A, Park S, Yang YH, Park MH, Kim B, Song IC, Sohn CH, Shin MS, Kim BN, Cho SC, Kim JW.
    Hum Brain Mapp; 2015 Jan 03; 36(1):367-77. PubMed ID: 25201318
    [Abstract] [Full Text] [Related]

  • 14. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI, Bijlenga D, Boonstra AM, Breuk M, Pardoen WF, Beekman AT, Kooij JJ.
    Eur Neuropsychopharmacol; 2014 Apr 03; 24(4):519-28. PubMed ID: 24508533
    [Abstract] [Full Text] [Related]

  • 15. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder.
    Schrantee A, Mutsaerts H, Bouziane C, Tamminga H, Bottelier MA, Reneman L.
    Neuroimage Clin; 2017 Apr 03; 13():123-129. PubMed ID: 27942455
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design.
    Bottelier MA, Schouw ML, Klomp A, Tamminga HG, Schrantee AG, Bouziane C, de Ruiter MB, Boer F, Ruhé HG, Denys D, Rijsman R, Lindauer RJ, Reitsma HB, Geurts HM, Reneman L.
    BMC Psychiatry; 2014 Feb 19; 14():48. PubMed ID: 24552282
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
    Wigal SB, Nordbrock E, Adjei AL, Childress A, Kupper RJ, Greenhill L.
    CNS Drugs; 2015 Apr 19; 29(4):331-40. PubMed ID: 25877989
    [Abstract] [Full Text] [Related]

  • 19. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder.
    Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L.
    Psychiatry Res Neuroimaging; 2017 Nov 30; 269():36-42. PubMed ID: 28938219
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.